In vitro effects of antiepileptic drugs on acetylcholinesterase and ectonucleotidase activities in zebrafish (Danio rerio) brain

Toxicology in Vitro

Volumn 24, Issue 4, 2010, Pages 1279-1284

  Siebel, A M ^a,b   Rico, E P ^c   Capiotti, K M ^a,b   Piato, A L ^a,b   Cusinato, C T ^a   Franco, T M A ^a   Bogo, M R ^a,b   Bonan, C D ^a,b  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina INCT TM   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Acetylcholinesterase; Antiepileptic drugs; Ecto 5' nucleotidase; Nucleoside triphosphate diphosphohydrolase; Zebrafish

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ADENOSINE TRIPHOSPHATE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; ECTO 5' NUCLEOTIDASE; GABAPENTIN; HYDROLASE; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; PHENYTOIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; IN VITRO STUDY; MALE; NONHUMAN; PROTEIN HYDROLYSIS; ZEBRA FISH;

5'-NUCLEOTIDASE; ACETYLCHOLINESTERASE; AMINES; ANIMALS; ANTICONVULSANTS; BRAIN; CARBAMAZEPINE; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-AMINOBUTYRIC ACID; PHENYTOIN; ZEBRAFISH;

DANIO RERIO;

EID: 77952938471     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2010.03.018     Document Type: Article

References (74)

1. Abbracchio M.P., Burnstock G., Verkhratsky A., Zimmermann H. Purinergic signalling in the nervous system: an overview. Trends in Neurosciences 2009, 32(1):19-29.
2. Badawy R.A.B., Harvey A.S., Macdonell R.A.L. Cortical hyperexcitability and epileptogenesis: understanding the mechanisms of epilepsy - part 1. Journal of Clinical Neuroscience 2009, 16:355-365.
3. Banerjee P.N., Filippi D., Hauser W.A. The descriptive epidemiology of epilepsy: a review. Epilepsy Research 2009, 85(1):31-45.
4. Baraban S.C. Emerging epilepsy models: insights from mice, flies, worms and fish. Current Opinion in Neurology 2007, 20(2):164-168.
5. Baraban S.C., Taylor M.R., Castro P.A., Baier H. Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience 2005, 131(3):759-768.
6. Barnes J.M., Murphy P.A., Kirkham D., Henley J. Interaction of guanine nucleotides with [3H] kainate and 6-[3H]cyano-7-nitroquinoxaline-2,3-dione binding in goldfish brain. Journal of Neurochemistry 1993, 61(5):1685-1691.
7. Bencan Z., Sledge D., Levin E.D. Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety. Pharmacology, Biochemistry and Behavior 2009, 94(1):75-80.
8. Berghmans S., Hunt J., Roach A., Goldsmith P. Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants. Epilepsy Research 2007, 75:18-28.
9. Bhattacharya S.K., Sen A.P., Mitra S.K. Effects of muscarinic receptor agonists and antagonists on response of non-extensor rats to maximal electroshock. Indian Journal of Experimental Biology 1991, 29(3):237-240.
10. Bialer M., White H.S. Key factors in the discovery and development of new antiepileptic drugs. Nature Reviews. Drug Discovery 2010, 9(1):68-82.
11. Boccia M.M., Acosta G.B., Baratti C.M. Memory improving actions of gabapentine in mice: possible involvement of central muscarinic cholinergic mechanism. Neuroscience Letters 2001, 311:153-156.
12. Boison D. Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. The Neuroscientist 2005, 11(1):25-36.
13. Boison D. Adenosine as a neuromodulator in neurological diseases. Current Opinion in Pharmacology 2008, 8(1):2-7.
14. Borowicz K.K., Kleinrok K., Czuczwar S.J. N6-2-4-aminophenyl/ethyl-adenosine enhances the anticonvulsive activity of antiepileptic drugs. European Journal of Pharmacology 1997, 372(2-3):125-133.
15. Borowicz K.K., Luszczki J., Czuczwar S.J. 2-Chloroadenosine, a preferential agonist of adenosine A1 receptors enhances the anticonvulsant activity of carbamazepine and clonazepam in mice. European Neuropsychopharmacology 2002, 12:173-179.
16. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:218-254.
17. Burnstock G. Cotransmission. Current Opinion on Pharmacology 2004, 4:47-52.
18. Burnstock G. Purinergic signalling: past, present and future. Brazilian Journal of Medical and Biological Research 2009, 42:3-8.
19. Burnstock G., Verkhratsky A. Evolutionary origins of the purinergic signalling system. Acta Physiologica 2009, 195:415-447.
20. Chan K.M., Delfert D., Junger K.D. A direct colorimetric assay for Ca2+-stimulated ATPase activity. Analytical Biochemistry 1986, 157:375-380.
21. Chen W., Guidotti G. Soluble apyrases release ADP during ATP hydrolysis. Biochemical and Biophysical Research Communications 2001, 282:90-95.
22. Chiang W.C., Knowles A.F. Inhibition of human NTPDase2 by modification of an intramembrane cysteine by p-chloromercuriphenylsulfonate and oxidative cross-linking of the transmembrane domains. Biochemistry 2008, 47(33):8775-8785.
23. Clemente D., Porteros A., Weruaga E., Alonso J.R., Arenzana F.J., Aijon J., Arevalo R. Cholinergic elements in the zebrafish central nervous system: histochemical and immunohistochemical analysis. Journal of Comparative Neurology 2004, 474:75-107.
24. Cognato G.P., Bruno A.N., da Silva R.S., Bog M.R., Sarkis J.J.F., Bonan C.D. Antiepileptic drugs prevent changes induced by pilocarpine model of epilepsy in brain ectonucleotidases. Neurochemical Research 2007, 32:1046-1055.
25. Cruickshank J.W., Brudzynski S.M., McLachlan R.S. Involvement of M1 muscarinic receptors in the initiation of cholinergically induced epileptic seizures in the rat brain. Brain Research 1994, 643:125-129.
26. Cunha R.A. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochemistry International 2001, 38:107-125.
27. D'Antuono M., Kawasaki H., Palmieri C., Cúria G., Biagini G., Avoli M. Antiepileptic drugs and muscarinic receptor-dependent excitation in the rat subiculum. Neuropharmacology 2007, 52:1291-1302.
28. Dickson C.T., Alonso A. Muscarinic induction of synchronous population activity in the entorhinal cortex. The Journal of Neuroscience 1997, 17:6729-6744.
29. Dunwiddie T.V., Masino S.A. The role and regulation of adenosine in the central nervous system. Annual Review of Neuroscience 2001, 24:31-55.
30. Ellman G.L., Courtney K.D., Andrés J.V., Feartherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology 1961, 7:88-95.
31. Fredholm B.B., Ijzerman A.P., Jacobson J.K., Klotz K., Linden J. International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacological Reviews 2001, 53(4):527-552.
32. Fredholm B.B., Chen J.F., Cunha R.A., Svenningsson P., Vaugeois J.M. Adenosine and brain function. International Review of Neurobiology 2005, 63:191-270.
33. Friedman A., Behrens C.J., Heinemann U. Cholinergic dysfunction in temporal lobe epilepsy. Epilepsia 2007, 48(5):126-130.
34. Gerlai R., Fernandes Y., Pereira T. Zebrafish (Danio rerio) responds to the animated image of a predator: towards the development of an automated aversive task. Behavioural Brain Research 2009, 201:318-324.
35. Grinthal A., Guidotti G. CD39, NTPDase1, is attached to the plasma membrane by two transmembrane domains. Why?. Purinergic Signalling 2006, 2:391-398.
36. Hamed S.A. The aspects and mechanisms of cognitive alterations in epilepsy: the role of antiepileptic medication. CNS Neuroscience and Therapeutics 2009, 15:134-156.
37. Horvat A., Orlic T., Banjac A., Momic T., Petrovic S., Demajo M. Inhibition of rat brain ecto-atpase activity by various drugs. General Physiology and Biophysics 2006, 25:91-105.
38. Hunsucker S.A., Mitchell B.S., Spychala J. The 5'-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacology and Therapeutics 2005, 107:1-30.
39. Ingham P.W. The power of the zebrafish for disease analysis. Human Molecular Genetics 2009, 18:107-112.
40. Kosmehl T., Hallare A.V., Braunbeck T., Hollert H. DNA damage induced by genotoxicants in zebrafish (Danio rerio) embryos after contact exposure to freeze-dried sediment and sediment extracts from Laguna Lake (The Philippines) as measured by the comet assay. Mutation Research 2008, 650:1-14.
41. Liu Z., Nagao T., Desjardins C.G., Gloor P., Avoli M. Quantitative evaluation of neuronal loss in the dorsal hippocampus in rats with longterm pilocarpine seizures. Epilepsy Research 1994, 17:237-247.
42. Loiseau P., Duche B. Carbamazepine clinical use. Antiepileptic Drugs 1995, 555-566. Raven Press, New York. fourth ed. R.H. Levy, R.H. Mattson, B.S. Meldrum (Eds.).
43. Luna-Tortós C., Fedrowitz M., Löscher W. Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy. Neuropharmacology 2010, 18:1-14.
44. Mello L.E., Cavalheiro E.A., Tan A.M., Kupfer W.R., Pretorius J.K., Babb T.L., Finch D.M. Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia 1993, 34:985-995.
45. Mizuno K., Okada M., Murakami T., Kamata G.Z., Kawata Y., Wada K., Kaneko S. Effects of carbamazepine on acetylcholine release and metabolism. Epilepsy Research 2000, 40:187-195.
46. Nagao T., Alonso A., Avoli M. Epileptiform activity induced by pilocarpine in the rat hippocampal-entorhinal slice preparation. Neuroscience 1996, 72:399-408.
47. Nakata H., Yoshioka K., Kamiya T., Tsuga H., Oyanagi K. Functions of heteromeric association between adenosine and P2Y receptors. Journal of Molecular Neuroscience 2005, 26(2-3):233-238.
48. Pankratov Y., Lalo U., Krishtal O.A., Verkhratsky A. P2X receptors and synaptic plasticity. Neuroscience 2009, 158:137-148.
49. Papanikolaou A., Papafotika A., Murphy C., Papamarcaki T., Tsolas O., Drab M., Kurzchalia T.V., Kasper M., Christoforidis S. Cholesterol-dependent lipid assemblies regulate the activity of the ectonucleotidase CD39. Journal of Biological Chemistry 2005, 15:26406-26414.
50. Pedrazza E.L., Senger M.R., Pedrazza L., Zimmermann F.F., Sarkis J.J.F., Bonan C.D. Sertraline and clomipramine inhibit nucleotide catabolism in rat brain synaptosomes. Toxicology In Vitro 2007, 21:671-676.
51. Pernot F., Carpentier P., Baille V., Testylier G.A., Beaup C., Foquin A., Filliat P., Liscia P., Coutan M., Piérard C., Béracochea D., Dorandeu F. Intrahippocampal cholinesterase inhibition induces epileptogenesis in mice without evidence of neurodegenerative events. Neuroscience 2009, 162(4):351-365.
52. Rico E.P., Senger M.R., Fauth M.G., Dias R.D., Bogo M.R., Bonan C.D. ATP and ADP hydrolysis in brain membranes of zebrafish (Danio rerio). Life Science 2003, 73:2071-2082.
53. Robson S.C., Sévigny J., Zimmermann H. The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signalling 2006, 2:409-430.
54. Rogawski M.A., Löscher W. The neurobiology of antiepileptic drugs. Nature Reviews. Neuroscience 2004, 5(7):553-564.
55. Sebastião A.M., Ribeiro J.A. Adenosine receptors and the central nervous system. Handbook of Experimental Pharmacology 2009, 193:471-534.
56. Seibt K.J., Oliveira R.L., Rico E.P., Dias R.D., Bogo M.R., Bonan C.D. Antipsychotic drugs inhibit nucleotide hydrolysis in zebrafish (Danio rerio) brain membranes. Toxicology In Vitro 2009, 23:78-82.
57. Seibt K.J., Oliveira R.L., Rico E.P., Dias R.D., Bogo M.R., Bonan C.D. Typical and atypical antipsychotics alter acetylcholinesterase activity and AChE expression in zebrafish (Danio rerio) brain. Comparative Biochemistry and Physiology. Toxicology and Pharmacology 2009, 150(1):10-15.
58. Senger M.R., Rico E.P., Dias R.D., Bogo M.R., Bonan C.D. Ecto-5'-nucleotidase activity in brain membranes of zebrafish (Danio rerio). Comparative Biochemistry and Physiology 2004, 139(2):203-207.
59. Shaked I., Zimmermann G., Soreq H. Stress-induced alternative splicing modulations in brain and periphery. Annals of the New York Academy of Science 2008, 1148:269-281.
60. Soreq H., Seidman S. Acetylcholinesterase: news roles for old actor. Nature Reviews. Neuroscience 2001, 2(4):294-302.
61. Stefan H., Feuerstein T.J. Novel anticonvulsant drugs. Pharmacology and Therapeutics 2007, 113:165-183.
62. Sträter N. Ecto-5'-nucleotidase: structure function relationships. Purinergic Signalling 2006, 2:343-350.
63. Sudha S., Lakshmanat M.K., Pradhan N. Chronic phenytoin induced impairment of learning and memory with associated changes in brain acetylcholine esterase activity and monoamine levels. Pharmacology Biochemistry and Behavior 1995, 52(1):119-124.
64. Suwalsky M., Mennickent S., Norris B., Villena F., Sotomayor C.P. Effects of the antiepileptic drug carbamazepine on human erythrocytes. Toxicology In Vitro 2006, 20:1363-1369.
65. Tonazzini I., Trincavelli M.L., Storm-Mathisen J., Martini C., Bergersen L.H. Co-localization and functional cross-talk between A1 and P2Y1 purine receptors in rat hippocampus. European Journal of Neuroscience 2007, 26:890-902.
66. Turski L., Ikonomidou C., Turski W.A., Bortolotto Z.A., Cavalheiro E.A. Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 1989, 3:154-171.
67. Yang L., Ho N.Y., Alshut R., Legradi J., Weiss C., Reischl M., Mikut R., Liebel U., Müller F., Strähle U. Zebrafish embryos as models for embryotoxic and teratological effects of chemicals. Reproductive Toxicology 2009, 28(2):245-253.
68. Yoshioka K., Nakata H. ATP- and adenosine-mediated signaling in the central nervous system purinergic receptor complex: generating adenine nucleotide-sensitive adenosine receptors. Journal of Pharmacological Sciences 2004, 94:88-94.
69. Zhu G., Okada M., Murakami T., Kawata Y., Kamata A., Kaneko S. Interaction between carbamazepine, zonisamide and voltage-sensitive Ca2+ channel on acetylcholine release in rat frontal cortex. Epilepsy Research 2002, 49(1):49-60.
70. Zimmermann H. Nucleotide signaling in nervous system development. European Journal of Physiology 2006, 452:573-588.
71. Zimmermann G., Soreq H. Termination and beyond: acetylcholinesterase as a modulator of synaptic transmission. Cell and Tissue Research 2006, 326:655-669.
72. Zimmermann H., Braun N., Kegel B., Heine P. New insights into molecular structure and function of ecto-nucleotidases in the nervous system. Neurochemistry International 1998, 32:421-425.
73. Zimmermann G., Njunting M., Ivens S., Tolner E., Behrens C.J., Gross M., Soreq M., Heinemann U., Friedman A. Acetylcholine-induced seizure-like activity and modified cholinergic gene expression in chronically epileptic rats. European Journal of Neuroscience 2008, 27:965-975.
74. Zuchora B., Wielosz M., Urbanska E.M. Adenosine A1 receptors and the anticonvulsant potential of drugs effective in the model of 3-nitropropionic acid-induced seizures in mice. European Neuropsychopharmacology 2004, 15:85-93.